Cardiology, university Fribourg Medical Center
Fribourg, 1708, Switzerland
Location status: Recruiting
Recruiting
NCT Number: NCT04185285
Percutaneous Coronary Intervention Registry FRIBOURG
The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital & university Fribourg.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
17 year–120 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All consecutive patients treated by percutaneous coronary intervention at our institution
- Able to give informed consent and willing to participate
Exclusion criteria
- Unwillingness to participate
- Enable to provide inform consent
Treatment and study plan
Percutaneous coronary intervention, stents
DevicePrimary outcomes
-
Patient-oriented composite endpoints (POCE)
Time frame: 2 years
Academic Research Consortium definition
-
Major Bleeding
Time frame: 2 years
Bleeding Academic Research Consortium definition
-
Patient-oriented composite endpoints (POCE)
Time frame: 5 years
Academic Research Consortium definition
-
Major Bleeding
Time frame: 5 years
Bleeding Academic Research Consortium definition
-
Patient-oriented composite endpoints (POCE)
Time frame: 10 years
Academic Research Consortium definition
-
Major Bleeding
Time frame: 10 years
Bleeding Academic Research Consortium definition
Secondary outcomes
-
all-cause death
Time frame: 2 years
Academic Research Consortium definition
-
any revascularization
Time frame: 2 years
Academic Research Consortium definition
-
any myocardial infarction
Time frame: 2 years
Academic Research Consortium definition
Interested in participating?
Recruiting
Interested in participating?
Request InfoSponsors and collaborators
Lead sponsor
University of Freiburg
Other
Registry information
Acronym: Cardio-FR
Important dates
- Study start
- 2015
- Primary completion
- 2017
- Study completion
- 2027
- First posted
- Dec 4, 2019
- Registry last updated
- Oct 22, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recruiting
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
NCT05427786
Arterial Occlusive Diseases, Arteriosclerosis
Seoul, South Korea
View Trial Details
Recruiting
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
NCT04416581
Acute Coronary Syndrome, Arterial Occlusive Diseases
Anyang, South Korea
View Trial Details
Recruiting
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
NCT05638867
Acute Coronary Syndrome, Arterial Occlusive Diseases
Beijing, Beijing Municipality, China
View Trial Details
Recruiting
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
NCT07582835
Acute Coronary Syndrome, Acute Coronary Syndromes
Lugano, Ch/ti, Switzerland
View Trial Details